个人简历

戴琴升，女，药理学博士，讲师，硕士生导师。2013年毕业于中国药科大学药理学专业。目前任职于中国药科大学工学院，同时担任基础医学与临床药学学院的细胞生物学实验平台（校级服务平台）的副主任。

研究领域

肿瘤药理学。多年来一直从事肿瘤发病机制与药物干预的研究、并在抗肿瘤药物的药效学及作用机制研究等方面做了大量研究工作。

近期论文

1、Dai Q, Yin Q, Wei L, Zhou Y, Qiao C, Guo Y, Wang X, Ma S, Lu N. Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells. Mol Carcinog. 2016 Aug;55(8):1275-89（IF 4.808）
2、Dai Q, Yin Q, Zhao Y, Guo R, Li Z, Ma S, Lu N. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 2015 Oct 5;764:353-62.（IF 2.73）
3、Dai Q, Yin Y, Liu W, Wei L, Zhou Y, Li Z, You Q, Lu N, Guo Q. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. Int J Biochem Cell Biol. 2013 Jul;45(7):1468-78.（IF 4.24）
4、Liu W, Dai Q（co-first author）, Lu N, Wei L, Ha J, Rong J, Mu R, You Q, Li Z, Guo Q. LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression. Biochem Cell Biol. 2011 Jun;89(3):287-98.（IF 2.637）
5、Dai QS, Liu W, Wang XB, Lu N, Gong DD, Kong LY, Guo QL. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Anticancer Drugs. 2011 Jan;22(1):46-57.（IF 2.407）